Global Human Growth Hormone (HGH) Market Share

Statistics for the 2023 & 2024 Global Human Growth Hormone (HGH) market share, created by Mordor Intelligence™ Industry Reports. Global Human Growth Hormone (HGH) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Hormones Research Human Growth Hormone Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Human Growth Hormone (HGH) Industry

The human growth hormone market is moderately consolidated, with a few market players controlling a significant market share. Furthermore, there are several active partnerships for the development of more efficacious and long-acting subtypes of human growth hormones. Some of the key market players include AnkeBio Co. Ltd, Eli Lilly and Company, Ferring BV, Novo Nordisk AS, Ipsen SA, Pfizer Inc., Genentech Inc. (Roche), and Teva Pharmaceutical Industries Ltd.

Human Growth Hormone Market Leaders

  1. AnkeBio Co. Ltd

  2. Eli Lilly and Company

  3. Ferring BV

  4. Novo Nordisk AS

  5. Ipsen S.A.

*Disclaimer: Major Players sorted in no particular order

Human Growth Hormone (HGH) Market Concentration

Growth Hormone Market Report Snapshots

Human Growth Hormone Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)